Accordingly, the current study might serve as a potential starting point to further explore the complex molecular implications of the epigenetic regulator NCOR2 and its components on processes involved in ovarian cancer development, such as GPER-mediated signaling pathways. The gene discussed is NCOR2; the disease is ovarian carcinoma.